Keywords
platelet-rich plasma
intradiscal injection
How to Cite
Abstract
Objective. This study aims to evaluate the effectiveness of intradiscal injection of platelet-rich plasma (PRP) in the treatment of discogenic pain syndrome of the lumbar spine.
Materials and Methods. The study was conducted from July 2022 to September 2024 at the SI “Institute of Traumatology and Orthopedics of NAMS of Ukraine.” Patients diagnosed with discogenic pain syndrome received intradiscal PRP injections. The effectiveness was assessed at 1 and 6 months post-treatment using the Visual Analog Scale (VAS), the Oswestry Disability Index (ODI), and MRI findings (Pfirrmann classification).
Results. One month after the injection, VAS scores decreased by more than 3 points in 21.2% of patients, by 2 points in 18.1%, and by 1 point in 39.3%. Six months after the injection, VAS scores decreased by more than 3 points in 54.5% of patients, by 2 points in 12.2%, and by 1 point in 21.2%. On average, VAS scores decreased by 30% one month after injection and by 46% six months after treatment compared to baseline. The average ODI scores decreased to 8.06% one month after injection and to 6.67% six months after injection, respectively. MRI evaluation of intervertebral disc changes using the Pfirrmann classification did not reveal statistically significant differences but showed a tendency toward a reduction in degenerative changes 6 months after the injection.
Conclusions. The use of platelet-rich plasma significantly reduced pain and improved quality of life in patients with discogenic pain syndrome who participated in the study 6 months after treatment initiation. It is also important to note that PRP therapy is safe due to the autologous nature of the product. Additionally, no clinically significant side effects or complications were observed. The results allow us to conclude that PRP therapy is effective in treating discogenic pain syndrome.
References
Cunningham LS, Kelsey JL. Epidemiology of musculoskeletal impairments and associated disability. Am J Public Health. 1984;74(6):574-9. doi: 10.2105/ajph.74.6.574.
Квасніцький М. Епідуральні інєкції в лікуванні корінцевого синдрому та хронічного болю в нижній частині спини при дегенеративно-дистрофічному ураженні хребта. Clin. and prev. med. 022;(1):78-9. https://doi.org/10.31612/2616-4868.1(19).2022.10
Kvasnitskyi M. Epidural injections in the treatment of radicular syndrome and chronic lumbar pain in degenerative-dystrophic spine damage. Clin. and prev. med. 2022;(1):78-9. https://doi.org/10.31612/2616-4868.1(19).2022.10 [in Ukrainian]
Manchikanti L, Singh V, Cash KA, Pampati V, Damron KS, Boswell MV. Effect of fluoroscopically guided caudal epidural steroid or local anesthetic injections in the treatment of lumbar disc herniation and radiculitis: a randomized, controlled, double blind trial with a two-year follow-up. Pain Physician. 2012;15(4):273-86.
Murakibhavi VG, Khemka AG. Caudal epidural steroid injection: a randomized controlled trial. Evid Based Spine Care J. 2011;2(4):19-26. doi: 10.1055/s-0031-1274753.
Slominski AT, Mahata B, Raman C, Bereshchenko O. Editorial: Steroids and Secosteroids in the Modulation of Inflammation and Immunity. Front Immunol. 2021;12: 825577. doi:10.3389/fimmu.2021.825577.
Alsousou J, Ali A, Willett K, Harrison P. The role of platelet-rich plasma in tissue regeneration. Platelets. 2013;24(3):173-82. doi: 10.3109/09537104.2012.684730.
Akeda K, An HS, Okuma M, Attawia M, Miyamoto K, Thonar EJ, et al. Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. Osteoarthritis Cartilage. 2006;14:1272–80.
Akeda K, An HS, Pichika R, Attawia M, Thonar EJ, Lenz ME, et al. Platelet-rich plasma (PRP) stimulates the extracellular matrix metabolism of porcine nucleus pulposus and annulus fibrosus cells cultured in alginate beads. Spine (Phila Pa 1976). 2006;31:959–66.
Ostelo RW, Deyo RA, Stratford P, Waddell G, Croft P, Von Korff M, et al. Interpreting change scores for pain and functional status in low back pain: towards international consensus regarding minimal important change. Spine (Phila Pa 1976). 2008;33(1):90–4. doi:10.1097/BRS.0b013e31815e3a10.
Roach KE, Brown MD, Dunigan KM, Kusek CL, Walas M. Test-retest reliability of patient reports of low back pain. J Orthop Sports Phys Ther. 1997;26:253–9.
Shafshak TS, Elnemr R. The Visual Analogue Scale Versus Numerical Rating Scale in Measuring Pain Severity and Predicting Disability in Low Back Pain. J Clin Rheumatol. 2021;27:282–5. doi:10.1097/RHU.0000000000001320
Fairbank JC, Pynsent PB. The Oswestry Disability Index. Spine (Phila Pa 1976). 2000;25:2940–52; discussion 2952.
Pfirrmann CW, Metzdorf A, Zanetti M, Hodler J, Boos N. Magnetic resonance classification of lumbar intervertebral disc degeneration. Spine (Phila Pa 1976). 2001;26(17):1873-8. doi: 10.1097/00007632-200109010-00011.
Akeda K, Ohishi K, Takegami N, Sudo T, Yamada J, Fujiwara T, et al. Platelet-Rich Plasma Releasate versus Corticosteroid for the Treatment of Discogenic Low Back Pain: A Double-Blind Randomized Controlled Trial. Journal of Clinical Medicine. 2022; 11(2):304. https://doi.org/10.3390/jcm1102030
Obata S, Akeda K, Imanishi T, Masuda K, Bae W, Morimoto R, et al. Effect of autologous platelet-rich plasma-releasate on intervertebral disc degeneration in the rabbit anular puncture model: a preclinical study. Arthritis Res Ther. 2012;14:R241. doi:10.1186/ar4084
Tuakli-Wosornu YA, Terry A, Boachie-Adjei K, Harrison JR, Gribbin CK, LaSalle EE, et al. Lumbar intradiskal platelet-rich plasma (PRP) injections: A prospective, double-blind, randomized controlled study. PM R. 2016;8:1–10. doi: 10.1016/j.pmrj.2015.08.010
Levi D, Horn S, Tyszko S, Levin J, Hecht-Leavitt C, Walko E. Intradiscal platelet-rich plasma injection for chronic discogenic low back pain: Preliminary results from a prospective trial. Pain Med. 2016;17:1010–1022. doi: 10.1093/pm/pnv053
This work is licensed under a Creative Commons Attribution 4.0 International License.